Evidence map›Paper›PMID 38114780›Full record

ArticleClinical drug investigation2024

Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis.

Egídio Freitas, Maria João Paiva Lopes, Maria João Cruz, Diogo Sousa, Ana Clara Valente, Bruno Duarte, Laetitia Teixeira, Gilberto Rosas, Mónica Caetano, Alberto Mota and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Clinical drug investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Real-World Effectiveness and Safety of JAK Inhibitors in Atopic Dermatitis: A Systematic Review and Meta-Analysis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Egídio FreitasDermatology Department, Centro Hospitalar Universitário do Santo António, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
Maria João Paiva LopesDermatology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Maria João CruzDermatology Department, Centro Hospitalar Universitário de São João, Porto, Portugal.
Diogo SousaDermatology Department, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.
Ana Clara ValenteDermatology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Bruno DuarteDermatology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Laetitia TeixeiraCenter for Health Technology and Services Research (CINTESIS), Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS.UP), Porto, Portugal.
Gilberto RosasDermatology Department, Centro Hospitalar Universitário de São João, Porto, Portugal.
Mónica CaetanoDermatology Department, Centro Hospitalar Universitário do Santo António, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
Alberto MotaDermatology Department, Centro Hospitalar Universitário de São João, Porto, Portugal.
Paulo FilipeDermatology Department, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.
Tiago TorresDermatology Department, Centro Hospitalar Universitário do Santo António, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal. torres.tiago@outlook.com.ORCID 0000-0003-0404-0870
Universidade do Porto · PTHospital de São João · PTUnidade Local de Saúde de São José · PTCentro Hospitalar Lisboa Norte · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AzetidinesDermatitis, AtopicDouble-Blind MethodHumansPurinesPyrazolesSeverity of Illness IndexSulfonamidesTreatment OutcomeAzetidinesbaricitinibPurinesPyrazolesSulfonamides

Identifiers

PMID38114780
OpenAlexW4389944674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.